The invention relates to the use of saccharide, such as lactose for the preparation of a medicament for the treatment andor prophylaxis of one or more symptoms caused by bacterial vaginosis, wherein the medicament comprises at least 20 percent by weight of saccharide, and wherein the medicament is substantially free from bacteria. The hub plate includes a first component which is attached to the hub, and a second component which is attached to a substrate. In another embodiment, the present invention relates to a composition having nanoparticles interacting with pigmentary titanium dioxide to provide for more uniform spacing of the titanium dioxide. Also, the first layer of transparent material has an index of refraction smaller than the substrate. A method and kit for securing wellhead equipment are also provided.